PIP - PharmAthene, Inc.

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Tiptopptrader, Jan 15, 2017.

  1. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    4,895
    Likes Received:
    1,124
    PharmAthene, Inc., a biodefense company, develops and commercializes medical counter measures against biological and chemical threats in the United States. The company focuses on developing lyophilized anthrax vaccines based on DepoVax, a proprietary technology platform that contributes recombinant protective antigen bulk drug substance. It serves National Institute of Allergy and Infectious Diseases, and the Biomedical Advanced Research and Development Authority. The company has a license agreement with ImmunoVaccine Technologies for the use of the DepoVax vaccine platform to develop an anthrax vaccine. PharmAthene, Inc. is headquartered in Annapolis, Maryland.

    [​IMG]
     
  2. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    4,895
    Likes Received:
    1,124
    Interesting chart, may have more upside potential

    upload_2017-1-15_9-37-30.png

    upload_2017-1-15_9-38-8.png
     
  3. twerpner

    twerpner Active Member

    Joined:
    Dec 20, 2016
    Messages:
    60
    Likes Received:
    27
    Tiptopptrader likes this.
  4. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    4,895
    Likes Received:
    1,124
  5. Timbo

    Timbo Active Member

    Joined:
    Jan 15, 2017
    Messages:
    347
    Likes Received:
    127
    Missed this one big time..
     

Share This Page